.svg){kind=small}
Oct-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Apotho Therapeutics has shown a notable improvement in its performance within the Pre-Roll category in Massachusetts. Over the past few months, the brand has climbed from a ranking of 60 in July 2025 to a more competitive position of 29 by October 2025. This upward trajectory indicates a strengthening market presence and growing consumer preference for their products. The brand's sales figures support this trend, with a significant increase from July to September, although there was a slight dip in October. Despite this minor setback, maintaining a spot within the top 30 suggests resilience and continued consumer interest in their offerings.
While Apotho Therapeutics has made commendable strides in Massachusetts, the absence of rankings in other states or provinces indicates potential areas for growth. Not being in the top 30 in other regions could suggest that the brand is either not widely distributed or not as competitive in those markets. This presents both a challenge and an opportunity for Apotho Therapeutics to explore strategies that could enhance its visibility and market share beyond Massachusetts. By analyzing successful tactics in Massachusetts and adapting them to other markets, the brand could potentially replicate its success and gain a foothold in new territories.
Competitive Landscape
In the Massachusetts Pre-Roll category, Apotho Therapeutics has demonstrated notable fluctuations in its market position over recent months. From July to October 2025, Apotho Therapeutics made a significant leap from being outside the top 50 to reaching a rank of 22 in September, before settling at 29 in October. This upward trajectory is indicative of a strategic improvement in market penetration or consumer preference, although the slight dip in October suggests competitive pressures. Notably, Fernway experienced a decline, dropping from rank 11 in July to 28 by October, which could have opened opportunities for Apotho Therapeutics to capture market share. Meanwhile, Resinate and Root & Bloom maintained relatively stable positions, with Resinate consistently ranking around 30 and Root & Bloom fluctuating slightly but remaining in the top 30. Springtime showed a volatile performance, dropping to 40 in September before recovering to 32 in October, which might have influenced Apotho Therapeutics' rank changes. Overall, Apotho Therapeutics' recent performance reflects a competitive edge in a dynamic market, although maintaining or improving its position will require continued strategic efforts amidst strong competition.
Notable Products
In October 2025, Apotho Therapeutics' top-performing product was the Golden Pupil Pre-Roll (1g) in the Pre-Roll category, maintaining its number one rank since August. The Gold Star Haze Pre-Roll (1g) made a strong debut at the second position, with sales reaching 3016 units. Honey Banana Pre-Roll (1g) and Crockett's Haze Pre-Roll (1g) secured the third and fourth positions, respectively, both showing notable sales figures. Black Domina Pre-Roll (1g) rounded out the top five, indicating a competitive market within the Pre-Roll category. This ranking highlights a consistent preference for the Golden Pupil, while new entries like Gold Star Haze showcase dynamic shifts in consumer interest.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
